HMMJ-U:CA:TSX-Global X Marijuana Life Sciences Index ETF (USD)

ETF | Others |

Last Closing

CAD 7.21

Change

-0.37 (-4.88)%

Market Cap

CAD 0.09B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.29 (-1.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

+0.07 (+0.21%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.13 (-0.65%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.29%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.44 (+0.96%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.13 (-0.54%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.07 (-0.68%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.14 (-0.62%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.68B

ETFs Containing HMMJ-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.15% 26% F 30% F
Dividend Return 1.10% 21% F 16% F
Total Return 4.24% 18% F 24% F
Trailing 12 Months  
Capital Gain 15.18% 48% F 50% F
Dividend Return 1.23% 15% F 11% F
Total Return 16.40% 41% F 42% F
Trailing 5 Years  
Capital Gain 6.50% 34% F 44% F
Dividend Return 15.78% 58% F 45% F
Total Return 22.28% 32% F 39% F
Average Annual (5 Year Horizon)  
Capital Gain 23.34% 97% N/A 86% B+
Dividend Return 23.37% 97% N/A 86% B+
Total Return 0.02% 16% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 60.12% 3% F 15% F
Risk Adjusted Return 38.87% 59% D- 56% F
Market Capitalization 0.09B 62% D 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.